Literature DB >> 25129396

Factors associated with gastrostomy tube dependence after concurrent chemoradiotherapy for hypopharyngeal cancer.

Shigeyuki Murono1, Akira Tsuji, Kazuhira Endo, Satoru Kondo, Naohiro Wakisaka, Tomokazu Yoshizaki.   

Abstract

PURPOSE: We aimed to identify tumor- and treatment-related factors predicting gastrostomy tube dependence after concurrent chemoradiotherapy (CCRT) for hypopharyngeal cancer.
METHODS: We performed a retrospective review of all patients with hypopharyngeal cancer treated with CCRT between 2002 and 2012 except for those with residual or recurrent disease at evaluation. The incidence of gastrostomy tube dependence, defined as complete or almost complete dependence on tube feeding, at 6 months after the completion of treatment was the endpoint. A total of 75 patients were analyzed in this study.
RESULTS: Twelve patients (16 %) showed gastrostomy tube dependence. Among tumor-related factors, the subsite (posterior wall versus pyriform sinus plus postcricoid) was the most significant factor correlated with gastrostomy tube dependence (p < 0.01 by multivariate analysis). The T category of the primary tumor was also correlated with gastrostomy tube dependence on univariate analysis (p < 0.01). Among treatment-related factors, the radiation dose was not associated with gastrostomy tube dependence. On the other hand, gastrostomy tube dependence was also correlated with the requirement of supportive nutrition with a nasogastric tube at the beginning of and during treatment (both p < 0.01).
CONCLUSION: Risk factors for gastrostomy tube dependence after the completion of CCRT for hypopharyngeal cancer were identified.

Entities:  

Mesh:

Year:  2014        PMID: 25129396     DOI: 10.1007/s00520-014-2388-8

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  16 in total

1.  Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

Authors:  J P Pignon; J Bourhis; C Domenge; L Designé
Journal:  Lancet       Date:  2000-03-18       Impact factor: 79.321

2.  Barriers to winning the battle with head-and-neck cancer.

Authors:  K Thomas Robbins
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-05-01       Impact factor: 7.038

3.  Outcomes after the use of gastrostomy tubes in patients whose head and neck cancer was managed with radiation therapy.

Authors:  Julie A Ames; Lucy Hynds Karnell; Anjali K Gupta; Todd C Coleman; Michael P Karnell; Douglas J Van Daele; Gerry F Funk
Journal:  Head Neck       Date:  2010-11-12       Impact factor: 3.147

4.  Objective assessment of swallowing function after definitive concurrent (chemo)radiotherapy in patients with head and neck cancer.

Authors:  Jaiprakash Agarwal; Vijay Palwe; Debnarayan Dutta; Tejpal Gupta; Sarbani Ghosh Laskar; Ashwini Budrukkar; Vedang Murthy; Pankaj Chaturvedi; Prathamesh Pai; Devendra Chaukar; Anil K D'Cruz; Suyash Kulkarni; Aniruddha Kulkarni; Gurmit Baccher; Shyam Kishore Shrivastava
Journal:  Dysphagia       Date:  2011-02-23       Impact factor: 3.438

5.  Concomitant radiation therapy and targeted cisplatin chemotherapy for the treatment of advanced pyriform sinus carcinoma: disease control and preservation of organ function.

Authors:  S Samant; P Kumar; J Wan; C Hanchett; F Vieira; T Murry; F S Wong; K T Robbins
Journal:  Head Neck       Date:  1999-10       Impact factor: 3.147

6.  Gastrostomy tube placement in patients with hypopharyngeal cancer treated with radiotherapy or chemoradiotherapy: factors affecting placement and dependence.

Authors:  Mihir K Bhayani; Katherine A Hutcheson; Denise A Barringer; Dianna B Roberts; Jan S Lewin; Stephen Y Lai
Journal:  Head Neck       Date:  2013-01-16       Impact factor: 3.147

7.  Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients.

Authors:  Jean-Pierre Pignon; Aurélie le Maître; Emilie Maillard; Jean Bourhis
Journal:  Radiother Oncol       Date:  2009-05-14       Impact factor: 6.280

8.  Hypopharyngeal dose is associated with severe late toxicity in locally advanced head-and-neck cancer: an RTOG analysis.

Authors:  Mitchell Machtay; Jennifer Moughan; Andrew Farach; Elizabeth Martin-O'Meara; James Galvin; Adam S Garden; Randal S Weber; Jay S Cooper; Arlene Forastiere; K Kian Ang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-11-15       Impact factor: 7.038

Review 9.  Dysphagia in head and neck cancer patients treated with chemoradiotherapy.

Authors:  Nele Platteaux; Piet Dirix; Eddy Dejaeger; Sandra Nuyts
Journal:  Dysphagia       Date:  2009-08-27       Impact factor: 3.438

10.  Intra-arterial cisplatin with concomitant radiation for advanced hypopharyngeal cancer.

Authors:  Kenichiro Nomura; Miki Takahara; Akihiro Katayama; Kan Kishibe; Isamu Kunibe; Akihiro Katada; Tatsuya Hayashi; Yasuaki Harabuchi
Journal:  Laryngoscope       Date:  2012-12-21       Impact factor: 3.325

View more
  3 in total

1.  Pretreatment factors associated with functional oral intake and feeding tube use at 1 and 6 months post-radiotherapy (+/- chemotherapy) for head and neck cancer.

Authors:  Molly K Barnhart; Elizabeth C Ward; Bena Cartmill; Rachelle A Robinson; Virginia A Simms; Sophie J Chandler; Elea T Wurth; Robert I Smee
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-06       Impact factor: 2.503

2.  Risk Stratification of Dysphagia After Surgical Treatment of Hypopharyngeal Cancer.

Authors:  Hye Ah Joo; Yoon Se Lee; Young Ho Jung; Seung-Ho Choi; Soon Yuhl Nam; Sang Yoon Kim
Journal:  Front Surg       Date:  2022-05-19

3.  A Retrospective Study of G-Tube Use in Japanese Patients Treated with Concurrent Chemoradiotherapy for Hypopharyngeal Cancer.

Authors:  Akihiro Homma; Hiromitsu Hatakeyama; Takatsugu Mizumachi; Satoshi Kano; Tomohiro Sakashita; Rinnosuke Kuramoto; Yuji Nakamaru; Rikiya Onimaru; Kazuhiko Tsuchiya; Daisuke Yoshida; Koichi Yasuda; Hiroki Shirato; Satoshi Fukuda
Journal:  PLoS One       Date:  2016-08-24       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.